In a newly published paper, lenalidomide was shown to increase EPOR levels by inhibiting the E3 ubiquitin ligase RNF41 in cells from the myeloid lineage involved in myelodysplastic syndrome. This evidence concerns the gene EPOR and myelodysplastic syndrome.